{"id":338312,"date":"2026-11-04T10:57:36","date_gmt":"2026-11-04T05:27:36","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=338312"},"modified":"2026-11-04T10:57:36","modified_gmt":"2026-11-04T05:27:36","slug":"compounder-stocks-to-buy","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/","title":{"rendered":"Compounder Stocks to Buy in November 2026: 5 Names on the Watchlist"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Ajanta Pharma Rs 3,320. Menon Bearings Rs 321.50. Dr Lal Rs 1,926. Elgi Equipments Rs 532.40. KFin Technologies Rs 861.60. NSE closing prices, 3 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Five compounder stocks to buy on the November 2026 watchlist are Ajanta Pharma, Menon Bearings, Dr Lal PathLabs, Elgi Equipments and KFin Technologies. All five grew revenue in their latest full year, and all five also grew net profit. Menon Bearings has the lowest P\/E at 34.27, while Ajanta Pharma leads on return on equity at 23.33%. Check each valuation against your own risk appetite before acting.<\/p>\n<\/p><\/div>\n<p>The compounder stocks to buy in November 2026 start with five listed names: Ajanta Pharma, Menon Bearings, Dr Lal PathLabs, Elgi Equipments and KFin Technologies. Compounder stocks are companies that grow profit every year while earning high returns on equity with little debt, so earnings build on themselves over time.<\/p>\n<p>This article ranks none of them as a sure thing. It lays out the numbers each company has reported, how the shares are priced today and what an investor should check before adding any of these compounder stocks to buy to a portfolio. All prices are NSE closing prices of 3 November 2026, and financials come from company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=compounder-stocks-to-buy\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Which_Are_the_Best_Compounder_Stocks_to_Buy_in_November_2026\" title=\"Which Are the Best Compounder Stocks to Buy in November 2026?\">Which Are the Best Compounder Stocks to Buy in November 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Why_These_Compounder_Stocks_to_Buy_Are_in_Focus\" title=\"Why These Compounder Stocks to Buy Are in Focus\">Why These Compounder Stocks to Buy Are in Focus<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Ajanta_Pharma_The_Branded_Generics_Specialist_Among_Compounder_Stocks_to_Buy\" title=\"Ajanta Pharma: The Branded Generics Specialist Among Compounder Stocks to Buy\">Ajanta Pharma: The Branded Generics Specialist Among Compounder Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Menon_Bearings_A_Small-Cap_Engine_Bearing_Maker_Among_Compounder_Stocks_to_Buy\" title=\"Menon Bearings: A Small-Cap Engine Bearing Maker Among Compounder Stocks to Buy\">Menon Bearings: A Small-Cap Engine Bearing Maker Among Compounder Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Dr_Lal_PathLabs_The_Diagnostics_Leader_Among_Compounder_Stocks_to_Buy\" title=\"Dr Lal PathLabs: The Diagnostics Leader Among Compounder Stocks to Buy\">Dr Lal PathLabs: The Diagnostics Leader Among Compounder Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Elgi_Equipments_The_Air_Compressor_Specialist_Among_Compounder_Stocks_to_Buy\" title=\"Elgi Equipments: The Air Compressor Specialist Among Compounder Stocks to Buy\">Elgi Equipments: The Air Compressor Specialist Among Compounder Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#KFin_Technologies_The_Registrar_and_Technology_Name_Among_Compounder_Stocks_to_Buy\" title=\"KFin Technologies: The Registrar and Technology Name Among Compounder Stocks to Buy\">KFin Technologies: The Registrar and Technology Name Among Compounder Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Growth_Snapshot_Latest_Full_Year_and_Latest_Quarter\" title=\"Growth Snapshot: Latest Full Year and Latest Quarter\">Growth Snapshot: Latest Full Year and Latest Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Factors_That_Move_Compounder_Stocks_to_Buy\" title=\"Factors That Move Compounder Stocks to Buy\">Factors That Move Compounder Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Risks_to_Keep_in_Mind_Before_Buying_Compounder_Stocks\" title=\"Risks to Keep in Mind Before Buying Compounder Stocks\">Risks to Keep in Mind Before Buying Compounder Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#How_to_Choose_Compounder_Stocks_to_Buy\" title=\"How to Choose Compounder Stocks to Buy\">How to Choose Compounder Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#How_to_Invest_in_Compounder_Stocks\" title=\"How to Invest in Compounder Stocks\">How to Invest in Compounder Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Frequently_Asked_Questions_on_Compounder_Stocks_to_Buy\" title=\"Frequently Asked Questions on Compounder Stocks to Buy\">Frequently Asked Questions on Compounder Stocks to Buy<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Which_are_the_best_compounder_stocks_to_buy_in_November_2026\" title=\"Which are the best compounder stocks to buy in November 2026?\">Which are the best compounder stocks to buy in November 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Is_Ajanta_Pharma_a_good_stock_to_buy_from_this_Compounder_list\" title=\"Is Ajanta Pharma a good stock to buy from this Compounder list?\">Is Ajanta Pharma a good stock to buy from this Compounder list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Are_these_compounder_stocks_expensive_right_now\" title=\"Are these compounder stocks expensive right now?\">Are these compounder stocks expensive right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Which_of_these_compounder_stocks_pay_a_dividend\" title=\"Which of these compounder stocks pay a dividend?\">Which of these compounder stocks pay a dividend?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#Which_stock_on_this_list_has_the_highest_return_on_equity\" title=\"Which stock on this list has the highest return on equity?\">Which stock on this list has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#What_are_the_risks_of_investing_in_compounder_stocks\" title=\"What are the risks of investing in compounder stocks?\">What are the risks of investing in compounder stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/compounder-stocks-to-buy\/#How_can_I_invest_in_compounder_stocks_in_India\" title=\"How can I invest in compounder stocks in India?\">How can I invest in compounder stocks in India?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Which_Are_the_Best_Compounder_Stocks_to_Buy_in_November_2026\"><\/span><strong>Which Are the Best Compounder Stocks to Buy in November 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The best compounder stocks to buy in November 2026 for a watchlist are Ajanta Pharma, Menon Bearings, Dr Lal PathLabs, Elgi Equipments and KFin Technologies. They were picked because each has complete reported financials, profit in the latest quarter and an NSE listing. The table puts their market data side by side.<\/p>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"6\">\n<thead>\n<tr>\n<th>Company<\/th>\n<th>CMP (Rs)<\/th>\n<th>Market Cap<\/th>\n<th>P\/E<\/th>\n<th>ROE<\/th>\n<th>Dividend Yield<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/ajantpharm\/ajanta-pharma-ltd-share-price-today\">Ajanta Pharma<\/a><\/td>\n<td>3,320<\/td>\n<td>Rs 43,234 crore<\/td>\n<td>38.10<\/td>\n<td>23.33%<\/td>\n<td>0.81%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/menonbe\/menon-bearings-ltd-share-price-today\">Menon Bearings<\/a><\/td>\n<td>321.50<\/td>\n<td>Rs 1,506 crore<\/td>\n<td>34.27<\/td>\n<td>20.64%<\/td>\n<td>0.74%<\/td>\n<\/tr>\n<tr>\n<td>Dr Lal PathLabs<\/td>\n<td>1,926<\/td>\n<td>Rs 32,115 crore<\/td>\n<td>58.78<\/td>\n<td>20.13%<\/td>\n<td>1.07%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/elgiequip\/elgi-equipments-ltd-share-price-today\">Elgi Equipments<\/a><\/td>\n<td>532.40<\/td>\n<td>Rs 16,281 crore<\/td>\n<td>36.36<\/td>\n<td>19.28%<\/td>\n<td>0.53%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/kfintech\/kfin-technologies-ltd-share-price-today\">KFin Technologies<\/a><\/td>\n<td>861.60<\/td>\n<td>Rs 14,910 crore<\/td>\n<td>42.76<\/td>\n<td>21.47%<\/td>\n<td>1.39%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>On valuation, Elgi Equipments trades below the industry P\/E; Ajanta Pharma, Menon Bearings, Dr Lal PathLabs and KFin Technologies sit close to it. Valuation is the first filter for any compounder stocks to buy list, and it is covered again in the risk section.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_These_Compounder_Stocks_to_Buy_Are_in_Focus\"><\/span><strong>Why These Compounder Stocks to Buy Are in Focus<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>In this list, net profit rose in each of the last three financial years, from FY24 to FY26, and return on equity ranges from about 19% to 23%. Debt to equity is 0.25 or lower for every company. The list covers a branded pharma company, an auto components maker, a diagnostics chain, an air compressor maker and a registrar and technology services company. Investors comparing the best compounder stocks in India usually check how long the growth record is and whether returns stay high as the business grows.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ajanta_Pharma_The_Branded_Generics_Specialist_Among_Compounder_Stocks_to_Buy\"><\/span><strong>Ajanta Pharma: The Branded Generics Specialist Among Compounder Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ajanta Pharma is a branded generics company with a strong presence in dermatology, ophthalmology and cardiology in India, Africa and Asia. Its market capitalisation is Rs 43,234 crore, the share price is Rs 3,320 and the P\/E of 38.10 compares with an industry P\/E of 37.65.<\/p>\n<p>Over FY26, net profit rose 14.7% to Rs 1,056 crore on revenue of Rs 5,625 crore, which was up 18.6%. The latest quarter, the June 2026 quarter, brought revenue of Rs 1,697 crore, up 27.7% year on year, and net profit of Rs 334 crore, up 30.9%.<\/p>\n<p>Return on equity is 23.33%, debt-to-equity is 0.06, and the dividend yield is 0.81%. Promoters hold 63.47%, foreign institutions 7.63% and domestic institutions 21.94% as of September 2026. Domestic institutional holding has risen from 17.90% to 21.94% over the last year.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Menon_Bearings_A_Small-Cap_Engine_Bearing_Maker_Among_Compounder_Stocks_to_Buy\"><\/span><strong>Menon Bearings: A Small-Cap Engine Bearing Maker Among Compounder Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Menon Bearings is a maker of engine bearings, bushes and aluminium die castings, mainly for automakers. The stock trades at Rs 321.50 with a market capitalisation of Rs 1,506 crore and a P\/E of 34.27, against an industry P\/E of 36.13.<\/p>\n<p>FY26 revenue rose 23.2% to Rs 300 crore and net profit rose 53.4% to Rs 38.2 crore. In the June 2026 quarter, revenue grew 37.0% year on year to Rs 94.3 crore, while net profit grew 67.4% to Rs 14.1 crore.<\/p>\n<p>Return on equity is 20.64%, debt-to-equity is 0.25, and the dividend yield is 0.74%. Promoters hold 66.66%, foreign institutions 0.21% and domestic institutions 2.16% as of September 2026. Domestic institutional holding has risen from 0.00% to 2.16% over the last year.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Compounder Stocks Live on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_PathLabs_The_Diagnostics_Leader_Among_Compounder_Stocks_to_Buy\"><\/span><strong>Dr Lal PathLabs: The Diagnostics Leader Among Compounder Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr Lal PathLabs is one of India&#8217;s largest diagnostic chains, with a national network of labs and collection centres. At Rs 1,926, the stock has a market capitalisation of Rs 32,115 crore and trades at 58.78 times earnings, while the industry P\/E is 61.50.<\/p>\n<p>Reported numbers show FY26 revenue of Rs 2,864 crore, up 12.1% year on year, with net profit at Rs 510 crore, up 3.6%. The June 2026 quarter added revenue of Rs 830 crore (up 18.9%) and net profit of Rs 170 crore (up 27.2%).<\/p>\n<p>Return on equity is 20.13%, debt-to-equity is 0.08, and the dividend yield is 1.07%. Promoters hold 52.93%, foreign institutions 18.73% and domestic institutions 21.58% as of September 2026. Domestic institutional holding has risen from 18.49% to 21.58% over the last year.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Elgi_Equipments_The_Air_Compressor_Specialist_Among_Compounder_Stocks_to_Buy\"><\/span><strong>Elgi Equipments: The Air Compressor Specialist Among Compounder Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Elgi Equipments is an air compressor maker with a large international business. Its market capitalisation is Rs 16,281 crore, the share price is Rs 532.40 and the P\/E of 36.36 compares with an industry P\/E of 42.61.<\/p>\n<p>Over FY26, net profit rose 22.8% to Rs 430 crore on revenue of Rs 4,068 crore, which was up 14.0%. The latest quarter, the June 2026 quarter, brought revenue of Rs 1,083 crore, up 22.1% year on year, and net profit of Rs 103 crore, up 20.7%.<\/p>\n<p>Return on equity is 19.28%, debt-to-equity is 0.24, and the dividend yield is 0.53%. Promoters hold 31.19%, foreign institutions 20.20% and domestic institutions 11.47% as of September 2026. Domestic institutional holding has risen from 6.25% to 11.47% over the last year.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"KFin_Technologies_The_Registrar_and_Technology_Name_Among_Compounder_Stocks_to_Buy\"><\/span><strong>KFin Technologies: The Registrar and Technology Name Among Compounder Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>KFin Technologies is a registrar and technology services company for mutual funds and issuers. The stock trades at Rs 861.60 with a market capitalisation of Rs 14,910 crore and a P\/E of 42.76, against an industry P\/E of 42.66.<\/p>\n<p>FY26 revenue rose 19.1% to Rs 1,344 crore and net profit rose 3.3% to Rs 344 crore. In the September 2026 quarter, revenue grew 28.1% year on year to Rs 410 crore, while net profit grew 7.5% to Rs 100 crore.<\/p>\n<p>Return on equity is 21.47%, and the dividend yield is 1.39%. Promoters hold 14.06%, foreign institutions 20.07% and domestic institutions 37.55% as of September 2026. Domestic institutional holding has risen from 24.80% to 37.55% over the last year.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track these compounder stocks live and get daily stock recommendations.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Growth_Snapshot_Latest_Full_Year_and_Latest_Quarter\"><\/span><strong>Growth Snapshot: Latest Full Year and Latest Quarter<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares year-on-year growth in revenue and net profit for all five compounder stocks, using filed results.<\/p>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"6\">\n<thead>\n<tr>\n<th>Company<\/th>\n<th>Full-Year Revenue Growth<\/th>\n<th>Full-Year Profit Growth<\/th>\n<th>Latest Quarter<\/th>\n<th>Quarter Revenue Growth<\/th>\n<th>Quarter Profit Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Ajanta Pharma<\/td>\n<td>18.6%<\/td>\n<td>14.7%<\/td>\n<td>Jun 2026<\/td>\n<td>27.7%<\/td>\n<td>30.9%<\/td>\n<\/tr>\n<tr>\n<td>Menon Bearings<\/td>\n<td>23.2%<\/td>\n<td>53.4%<\/td>\n<td>Jun 2026<\/td>\n<td>37.0%<\/td>\n<td>67.4%<\/td>\n<\/tr>\n<tr>\n<td>Dr Lal PathLabs<\/td>\n<td>12.1%<\/td>\n<td>3.6%<\/td>\n<td>Jun 2026<\/td>\n<td>18.9%<\/td>\n<td>27.2%<\/td>\n<\/tr>\n<tr>\n<td>Elgi Equipments<\/td>\n<td>14.0%<\/td>\n<td>22.8%<\/td>\n<td>Jun 2026<\/td>\n<td>22.1%<\/td>\n<td>20.7%<\/td>\n<\/tr>\n<tr>\n<td>KFin Technologies<\/td>\n<td>19.1%<\/td>\n<td>3.3%<\/td>\n<td>Sep 2026<\/td>\n<td>28.1%<\/td>\n<td>7.5%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Factors_That_Move_Compounder_Stocks_to_Buy\"><\/span><strong>Factors That Move Compounder Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Four factors tend to drive compounder stocks, and each one is worth checking before a purchase.<\/p>\n<ul>\n<li><strong>Profit record:<\/strong> Rising profit every year is the base of compounding.<\/li>\n<li><strong>Return on equity:<\/strong> High returns let the business grow without much debt.<\/li>\n<li><strong>Low debt:<\/strong> Light borrowings protect the growth path.<\/li>\n<li><strong>Valuation:<\/strong> Reliable growers often trade at premium multiples.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Keep_in_Mind_Before_Buying_Compounder_Stocks\"><\/span><strong>Risks to Keep in Mind Before Buying Compounder Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The first risk is valuation, since a long growth record is usually reflected in the share price. The second is that three years is a short window, so older records and the next few quarters also matter. Review results every quarter.<\/p>\n<p>On the numbers, Dr Lal PathLabs trades at the highest P\/E on this list at 58.78, so its earnings need to keep growing to support the price. Compounder stocks to buy can still fall when markets turn weak, and a staggered entry has historically suited investors better than a lump-sum purchase.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Compounder_Stocks_to_Buy\"><\/span><strong>How to Choose Compounder Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Check the record:<\/strong> Look beyond three years if you can.<\/li>\n<li><strong>Review ROE:<\/strong> Returns should hold as the business grows.<\/li>\n<li><strong>Study cash flow:<\/strong> Profit should be backed by cash.<\/li>\n<li><strong>Compare valuations:<\/strong> Look at P\/E against growth.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Compounder_Stocks\"><\/span><strong>How to Invest in Compounder Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ol>\n<li>Shortlist two or three companies from this list that match your risk appetite.<\/li>\n<li>Open the Univest Screener and compare P\/E, ROE and debt for each stock.<\/li>\n<li>Check the latest quarterly results and shareholding pattern on NSE or BSE.<\/li>\n<li>Decide an amount you can hold for three to five years and split it into two or three purchases.<\/li>\n<li>Review the holding after every quarterly result instead of reacting to daily price moves.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Menon Bearings offers the lowest P\/E on this list at 34.27, Ajanta Pharma has the highest return on equity at 23.33%, and Menon Bearings posted the fastest net profit growth in its latest full year at 53.4%. Among the best compounder stocks in India, these five give investors a spread of size, valuation and growth, so the right pick depends on risk appetite and holding period. Spread the entry, keep position sizes sensible and consult a SEBI-registered advisor before investing in any of these compounder stocks to buy.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Compounder_Stocks_to_Buy\"><\/span><strong>Frequently Asked Questions on Compounder Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_compounder_stocks_to_buy_in_November_2026\"><\/span><strong>Which are the best compounder stocks to buy in November 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The five compounder stocks on the November 2026 watchlist are Ajanta Pharma, Menon Bearings, Dr Lal PathLabs, Elgi Equipments and KFin Technologies. Menon Bearings has the lowest P\/E at 34.27, Ajanta Pharma has the highest ROE at 23.33%, and Menon Bearings grew net profit 53.4% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Ajanta_Pharma_a_good_stock_to_buy_from_this_Compounder_list\"><\/span><strong>Is Ajanta Pharma a good stock to buy from this Compounder list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ajanta Pharma is the largest company on this list with a market capitalisation of Rs 43,234 crore and a P\/E of 38.10 against an industry P\/E of 37.65. Its FY26 revenue rose 18.6% and net profit rose 14.7%, with return on equity at 23.33%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_these_compounder_stocks_expensive_right_now\"><\/span><strong>Are these compounder stocks expensive right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Valuations vary across the group. Ajanta Pharma trades at a P\/E of 38.10, Menon Bearings trades at a P\/E of 34.27, Dr Lal PathLabs trades at a P\/E of 58.78, Elgi Equipments trades at a P\/E of 36.36, KFin Technologies trades at a P\/E of 42.76, against industry multiples ranging from 36.13 to 61.50. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_compounder_stocks_pay_a_dividend\"><\/span><strong>Which of these compounder stocks pay a dividend?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dividend yields on this list are Ajanta Pharma 0.81%, Menon Bearings 0.74%, Dr Lal PathLabs 1.07%, Elgi Equipments 0.53%, KFin Technologies 1.39%. Yields are modest across the group, so most investors look at these stocks for growth in earnings rather than for income, and payouts can change with company profits.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_stock_on_this_list_has_the_highest_return_on_equity\"><\/span><strong>Which stock on this list has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ajanta Pharma has the highest ROE on this list at 23.33%, followed by KFin Technologies at 21.47% and Menon Bearings at 20.64%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_compounder_stocks\"><\/span><strong>What are the risks of investing in compounder stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are premium valuations, a short three-year window and a possible slowdown in growth. On this list, Dr Lal PathLabs trades at the highest P\/E of 58.78, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_compounder_stocks_in_India\"><\/span><strong>How can I invest in compounder stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P\/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best compounder stocks to buy in November 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The five compounder stocks on the November 2026 watchlist are Ajanta Pharma, Menon Bearings, Dr Lal PathLabs, Elgi Equipments and KFin Technologies. Menon Bearings has the lowest P\/E at 34.27, Ajanta Pharma has the highest ROE at 23.33%, and Menon Bearings grew net profit 53.4% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.\"}},{\"@type\":\"Question\",\"name\":\"Is Ajanta Pharma a good stock to buy from this Compounder list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Ajanta Pharma is the largest company on this list with a market capitalisation of Rs 43,234 crore and a P\/E of 38.10 against an industry P\/E of 37.65. Its FY26 revenue rose 18.6% and net profit rose 14.7%, with return on equity at 23.33%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.\"}},{\"@type\":\"Question\",\"name\":\"Are these compounder stocks expensive right now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Valuations vary across the group. Ajanta Pharma trades at a P\/E of 38.10, Menon Bearings trades at a P\/E of 34.27, Dr Lal PathLabs trades at a P\/E of 58.78, Elgi Equipments trades at a P\/E of 36.36, KFin Technologies trades at a P\/E of 42.76, against industry multiples ranging from 36.13 to 61.50. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.\"}},{\"@type\":\"Question\",\"name\":\"Which of these compounder stocks pay a dividend?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dividend yields on this list are Ajanta Pharma 0.81%, Menon Bearings 0.74%, Dr Lal PathLabs 1.07%, Elgi Equipments 0.53%, KFin Technologies 1.39%. Yields are modest across the group, so most investors look at these stocks for growth in earnings rather than for income, and payouts can change with company profits.\"}},{\"@type\":\"Question\",\"name\":\"Which stock on this list has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Ajanta Pharma has the highest ROE on this list at 23.33%, followed by KFin Technologies at 21.47% and Menon Bearings at 20.64%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in compounder stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are premium valuations, a short three-year window and a possible slowdown in growth. On this list, Dr Lal PathLabs trades at the highest P\/E of 58.78, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.\"}},{\"@type\":\"Question\",\"name\":\"How can I invest in compounder stocks in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P\/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Five compounder stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for Ajanta Pharma, Menon Bearings, Dr Lal, Elgi Equipments and KFin Technologies.<\/p>\n","protected":false},"author":34,"featured_media":338310,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[13959,19461,15514,7536,8479],"class_list":["post-338312","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-ajanta-pharma","tag-compounder-stocks","tag-compounding-stocks","tag-dr-lal-pathlabs","tag-elgi-equipments"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["338310"],"rank_math_title":["Compounder Stocks to Buy in Nov 2026: Top 5 Picks"],"rank_math_description":["Compounder stocks to buy in November 2026: Ajanta Pharma, Menon Bearings, Dr Lal and Elgi Equipments, with FY26 growth, valuation, ROE and key risks for each."],"rank_math_focus_keyword":["compounder stocks to buy"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/compounder-stocks-to-buy-in-november-2026-5-names-on-the-watchlist.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/338312","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=338312"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/338312\/revisions"}],"predecessor-version":[{"id":338314,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/338312\/revisions\/338314"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/338310"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=338312"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=338312"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=338312"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}